Svetlana Dey, Director at Bluejay Diagnostics, Inc. (BJDX), bought 500 shares at $3.07 ($2K) on 2023-12-13, disclosed to the SEC on 2023-12-14.
Open-market purchase of $2k BJDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |